Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression.

Clinical trial NCT03242382 · UNKNOWN

Trial details

NCT number: NCT03242382
Sponsor: Grupo Espanol de Investigacion en Sarcomas
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Soft-tissue Sarcoma Osteosarcoma Chordoma

Start date: 2017-03-31
Primary completion: 2024-09-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.